---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-305076"
form_type: "8-K"
ticker: "EQ"
cik: "0001746466"
company_name: "Equillium, Inc."
filed_at: "2022-12-15T23:59:59+00:00"
generated_at: "2026-06-21T04:14:21.413555+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Equillium amends merger disclosures following three Metacrine stockholder lawsuits

## Summary
- Three lawsuits filed by Metacrine stockholders challenge disclosures in joint proxy for merger with Equillium.
- Equillium and Metacrine voluntarily supplement proxy with new details on deal background, valuation analyses, and projections.
- Supplement includes corrected PIPE study data, revised comparable company analysis, and updated discounted cash flow projections.
- Initial proposal valued Metacrine at ~$28M; final offer of $37.5M all-stock plus CVRs up to $22.5M for MET642 milestones.
- Companies deny allegations but add disclosures to avoid nuisance and delay; no admission of materiality.

## SEC filing metadata
- accession: 0001193125-22-305076
- form_type: 8-K
- ticker: EQ
- cik: 0001746466
- company_name: Equillium, Inc.
- filed_at: 2022-12-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1746466/000119312522305076/0001193125-22-305076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1746466/000119312522305076/d429598d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-305076
- JSON: https://secwatch.observer/filing/0001193125-22-305076.json
- Plain text: https://secwatch.observer/filing/0001193125-22-305076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.